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Abstract. Wound healing is a physiological process that occurs progressively through 
overlapping phases. Tissue oxygenation is an important part of the complex regulation for 
wound healing. Hyperbaric Oxygen (HBO) therapy is a method of increasing oxygen delivery 
to tissues. The therapy improves tissue oxygenation and stimulates the formation of H2O2 as a 
secondary messenger for Tumour Necrosis Factor alpha (TNF α), e-NOS, VEGF and Nuclear 
Factor Kappa Beta phosphorylation (NF-Kb) which play an important role in the rapid 
transcription of a wide variety of genes in response to extracellular stimuli. This study aims to 
determine the effects of Hyperbaric Oxygen therapy in enhancing the expressions of e-NOS, 
TNF-α, VEGF and wound healing. This study is an animal study with a ‘randomized control 
group of pre-test and post test design’ on 28 Wistar rats. Randomly, the rats were divided into 
4 groups with 7 rats in each group. The HBO treatment group 1 received 5 sessions of HBO 
2.4 ATA in 3x30 minutes; the HBO treatment group 2 received 10 sessions of HBO 2.4 ATA 
in 3x30 minutes; and each of the control groups were without HBO. Each of the 28 male rats 
were given a full thickness excisional wound of 1x1cm. Examinations of e-NOS, TNF-α, 
VEGF expressions and wound healing were performed on day-0 (pre-HBO) and day-5 HBO or 
on day-0 (pre-HBO) and day-10 HBO.The resultsshowthat the Hyperbaric Oxygen therapy can 
improve e-NOS (p=0.02), TNF-α (p= 0.02), VEGF expression (p=0.02) and wound healing 
(p=0.002) significantly in the provision of HBO 2.4 ATA for 3x30 minutes in 5 sessions over 5 
consecutive days. While the 10 sessions of HBO 2.4 ATA for 3x30 minutes over 10 
consecutive days only increase e-NOS (p=0.02), TNF-α (p=0.04), VEGF expression 
significantly (p=0.03) but do not improve wound healing significantly (p=0.3) compared with 
no HBO. The study concludes that HBO can improve the expressions of e-NOS, TNF-α, 
VEGF and wound healing in the provision of HBO 2.4 ATA for 3x30 minutes in 5 sessions, 
while the 10 sessions of HBO 2.4 ATA for 3x30 minutes only increase e-NOS, TNF-α, VEGF 
expression but do not improve wound healing. 
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1.  Introduction 
Wound healing is a normal process through a highly complex mechanism. The process occurs 
progressively through overlapping phases; haemostasis, inflammatory, proliferation, contraction and 
tissue remodelling [1]. The healing process can be ended by fibrosis or scarring even in optimal 
conditions, resulting in multiple disabilities [2] Acute injuries can become chronic wounds. The 
problem of chronic wounds is now a challenge for modern society resulting economically and socially 
significant medical impact. A Chronic wound is one of the most frequent causes of morbidity in 
developing countries [3]. 
An estimated 1.5% incident of the population suffered injuries at any points in time. Laceration or 
wound often encountered daily (estimated at 20 million cases each year) as a result of cut. A post 
operation wound is the biggest cause of skin trauma. There are more than 110 million surgical 
incisions every year, some which can’t recover completely due to various causes. The wound 
developed into chronic wounds .The large number of the population and the burden of costs require 
serious attention on early detection, prevention, diagnosis and treatment of chronic wounds [2]. 
The Hyperbaric Oxygen therapy, as an adjuvant therapy in wound healing, results an increase in 
RNS mainly in NO through iNOS and e-NOS, as well as an increase in ROS, especially H2O2. 
Excessive doses of RNS and ROS are a threat to the survival of the cells, while the therapeutic doses 
(2.4 ATA) of HBO provide positive benefits for wound healing [4]. In clinical use, the dose of HBO is 
restricted from 2-2.5 ATA to a maximum of 3 ATA for 60-120 minutes. The HBO therapy varies 
between 5-30 times [5]. The provision of 100% oxygen at a pressure of 2 ATA improves tissue 
oxygenation of 30-40 mmHg in normal circumstances up to 250-300 mmHg, while the pressure of 3 
ATA allows the improved tissue oxygenation up to 10-15 times [6].The Hyperbaric Oxygentherapy 
increases tissue oxygenation and stimulates the formation of H2O2 as a secondary messenger for the 
phosphorylation of Nuclear Factor Kappa Beta (NF-kB). The Nuclear Factor Kappa Beta/Rel 
transcription proteins play an important and quick role on a wide variety of genes in response to 
extracellular stimuli. Many aspects of the inflammatory response are also regulated by NF-kB, 
including the production factors of complement cascade and the induction of proinflammatory 
cytokines such as IL1 and TNF α [7] 
The Tumour Necrosis Factor (TNF) group consists of 19 cytokines which have an important role in 
regulating the development and functions of the immune system. Cytokines from the group of Tumour 
Necrosis Factor (TNF) regulates the inflammatory and immune processes. The lack of TNF can trigger 
cell deaths. Although TNF-α cytotoxicity affects some tumour cells, TNF α will only trigger apoptosis 
if the NFkB signalling is inhibited. TNF α is an activator ofNFkB, proinflammatory transcription 
factors that help cells survival through activation of pro-survival genes and suppression of pro-
apoptotic genes. 
Neovascularization holds a central function in wound healing. In vitro studies indicate that VEGF, 
the most potent angiogenic protein, was induced by NO. Barriers will disrupt NO synthesis of VEGF 
expression and angiogenesis, thus slowing down the process of wound healing. 
The Hyperbaric Oxygen therapy suppresses the inflammatory response to prevent chronic wounds 
[8] Supplementary oxygen through the blood stream accelerate sangiogenesis in ischemic wounds. 
Therefore, accelerates the healing time [6]. Numerous studies have proven the benefits of ATA 2.4 
HBO five sessions and ten sessions [9] 
Our previous studies result that HBO increases the expression of iNOS (p = 0.001), while the 
wound healing (p = 0.002) significant at 2.4 ATA HBO administration for 3x30 minutes in 5 sessions. 
Furthermore, the provision of 2.4 ATA HBO for 3x340 minutes in 10 sessions only enhance the 
expression of iNOS significantly (p = 0.002) but does not improve wound healing significantly (p = 
0.3) compared with no HBO administration [10]. 
This study aims to determine the influence of the Hyperbaric Oxygen therapy (HBO) to increase 
the expression of TNF-α and its relationship with the increased expressions of e-NOS, TNF-α and 
VEGF in wound healing. This study tests the influence of hyperbaric oxygen therapy (HBO) to the 
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increase of eNOS, TNFα and VEGF expression by the immune histochemical examination and the 
macroscopic wound healing process by measuring the area of wound closure on Rattusnorvegicus 
Wistargallus. The results are expected to be a reference for drafting standard operational procedures 
(SOPs) of the use of hyperbaric oxygen therapy (HBO) for wound healing in health care centres. 
 
2.  Methods 
This study was randomized by a controlled group of the pre test-post test designed in 28 Wistar rats. 
The samples were divided into 4 groups by random allocation, each consists of 7 rats. Treatment group 
1 was given HBO 2.4 ATA for 3x30 minutes in 5 sessions; the treatment group 2was given HBO 2.4 
ATA for 3x30 minutes in 10 sessions, and each of the control groups were without HBO. Allof the 28 
rats were given a 1x1cm full-thickness excisional wound. An immunohistochemical examination of 
the expressions of eNOS, TNFα, VEGF and the wound size measurement were conducted to 
determine the wound healing. The immunohistochemical examination and the wound size 
measurement to the treatment group 1 and the control group 1 were conducted on day 0 (pre-HBO) 
and day 5 of the HBO therapy. The immunohistochemical examination and the wound size 
measurement on the treatment group 2 and the control group 2 were conducted on day 0 and day 10 of 
the HBO. 
 
3. Results and discussion 
The study was conducted after the experimental animals had been acclimatized for 7 days. 
Skin tissue sampling was done by making a full-thickness of 1x1 cm excisional wound on the 
dorsal part of the experimental animals. The skin tissue sampling on day 0 was performed on 
all animals (a total of 28 samples) in the treatment group and the control group. The treatment 
group was given Hyperbaric Oxygen treatment in 5 sessions and 10 sessions. Comprehensive 
measurement of a wound closure and tissue sampling were done after the treatment of 
Hyperbaric Oxygen on day 5 (a total of 14 samples) and on day 10 (a total of 14 samples). 
The slides was made and immunohistochemical staining was conducted. 
Immunohistochemical examination for e-NOS, TNF-α and VEGF expressions was 
conducted under a microscope. This examination was intended to count the number of 
immunoreactive cells against e-NOS, TNF-α and VEGF. The quantitative data obtained by 
counting the number of cells in 10 different fields of view at 40x magnification. 
 
3.1. Day 0 (Pre HBO) condition of variables of expressions of e-NOS, TNF-α, VEGF, and 
wound healing 
The examination of e-NOS, TNF-α, VEGF expressions and wound healing done in groups 
with and without HBO while the extent of pre HBO wound receives the same treatment, i.e. 
full thickness of1x1cm (100 mm
2
)excisional wound size. On day 0 the expressions of e-NOS, 
TNF-α and VEGF in inflammatory cells with low intensity were observed. 
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Figure 1. Average HBO on Day 0; Variables of expressions of 
eNOS, TNFα, VEGF and wound size 
 
3.2. HBO condition of variables of expressions of e-NOS, TNF-α, VEGF and wound healing 
on day 5 
The administration of HBO 2.4 ATA for 3x30 minutes in 5 sessions conducted in the 
treatment group, followed by an examination of e-NOS, TNF-α, VEGF expressions and the 
wound size to the treatment group and the control group. Figure 2 shows the average results 
of the variable expressions of e-NOS, TNFα, VEGF and the wound size. On day 5 there are 
increased of e-NOS, TNF-α, VEGF expressions with high intensity in the treatment group and 
the control group. The increased expressions of e-NOS, TNF-α, VEGF in the treatment group 
are higher than those in the control group. Meanwhile, the wound healing in the HBO 
treatment group is higher than that in the control group (smaller wound size and better 
healing). 
 
 
 
 
Figure 2 Average HBO on day 5; Variables of Expressions of e-
NOS, TNF-α, VEGF, and wound size 
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3.3. HBO condition on day 10; variables of expressions of e-NOS, TNF-α, VEGF, and 
wound size 
The HBO administration of 2.4 ATA in 3x30 minute each session was conducted 10 times in 
the treatment group and followed by an examination of the expressions of e-NOS, TNF-α, 
VEGF and the wound size to the treatment group and the control group of HBO 
administration on day 10. Figure 3 shows that the intensity of the expressions of e-NOS, 
TNFα, VEGF were still high but lower than that of on day 5. There is no significant 
difference of the wound healing variable between the treatment group and the control group. 
 
 
 
Figure 3. Average HBO on Day 10; e-NOS, TNF-α, VEGF 
Expressions and Wound size 
 
 
 
Figure 4. TNFα Expressions using a light microscope Olympus CX31 objective 
magnification 40x. A: control group day 0, B: control group day-5, C: control 
group day 10, D: treatment group day 0, E: treatment group day-5, F: treatment 
group day 10. The intensity of expression of TNF-α is still low in the control 
group day 0 but the day-5 intensity increases the expression of TNF-α, then the 
10
th
 day intensity of the expression of TNFα declines again. 
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Figure 5. Expressions of e-NOS under a light microscope Olympus CX31 objective 
magnification 40x. A: control group day 0, B: control group day5, C: control group 
day 10, D: treatment group day0, E: treatment group day5, F: treatment group day 
10. In the control group day 0, the e-NOS expression remains in low intensity; The 
intensity of e-NOS expression increases on day 5 but declines again on the 10
th
 day. 
 
 
 
Figure 6. VEGF Expressions under a light microscope Olympus CX31objective 
magnification 40x. A: control group day 0, B: control group day5, C: control group 
day 10, D: treatment group day 0, E: treatment group day5, F: treatment group day 
10.  The intensity of VEGF expression is low in the control group day 0; The 
VEGF expression intensity increases on the 5th day but decreases again on the 10th 
day. 
 
The results of examination on the expressions of e-NOS, TNFα and VEGF in the treatment 
group and the control groups on day0 show that the expressions of e-NOS, TNF-α and VEGF 
intensity are low (1-1). After the administration of HBO 2.4 ATA in five sessions, on the 5th 
day there seems to be increased expressions of e-NOS, TNF-α and VEGF (2-2) along with the 
increased number of inflammatory cells, in which the increased expressions of e-NOS, TNF-α 
and VEGF in the treatment group is significantly higher than those of the control groups. On 
the 10th day the intensity of the expressions of e-NOS, TNF-α, VEGF is still high. However, 
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the number of cells that express them reduces and the number of inflammatory cells remains 
high (2-1). 
TNFα is a cytokine regulator and major effectors, mainly secreted by monocytes and 
macrophages that have been stimulated [11]. HBO administration increases the production of 
e-NOS in cultured endothelial cells [12]. Several biological processes and growth factors are 
stimulated and increased with Hypoxia and HBO. Such processes include angiogenesis, 
collagen synthesis, the activity of osteoclasts, and the release of VEGF and TNF-α. Oxygen 
stimulates biological processes under conditions of hypoxia and hyperoxia. It is called 
Oxygen Paradox. One mechanism for forming collagen fibroblasts is stimulated through 
peroxide. This occurs in HBO hypoxia wounds and during therapy. Peroxide formed in the 
HBO therapy resembles the stimulus that occurs during hypoxia. Another mechanism is 
cytokine stimulation which begins with hypoxia, and increases in cytokine regulation which is 
supported by the presence of hyperoxia occurring in the HBO therapy. VEGF, TNF-α TGF-β 
and PDGFβ are released at wound hypoxia as an initial stimulus, but its activity increases in 
hyperoxia conditions, especially in the presence of lactic acid [13]. 
The evidence shows that HBO can accelerate wound healing through mechanisms 
expressions of e-NOS, TNFα and VEGF in the inflammatory phase and the proliferative 
phase. The administration of HBO can potentially be used for a post-surgical adjuvant therapy 
for certain cases, thus it is expected to reduce the duration of treatment (Length of Stay / 
LOS) in the hospital. Indeed, it is expected to reduce the cost and recovery time for patients 
after surgery so that patients can be immediately productive and return to their normal 
activities. Therefore, we need to do more research on the effects of hyperbaric oxygen therapy 
against various types of wounds, including wounds that are conventionally difficult to cure, 
post-trauma wounds and postoperative wounds. 
The evidence also shows that the administration of HBO continuously for a long time does 
not provide significant benefits for wound healing. Therefore, time off (recovery time) needs 
to be given after administration of certain HBO in 5 sessions before continuing to the next 
session. Further research is needed to determine whether or not there are effects of the 
recovery period and the range of speeds of the wound healing/recovery time interval before 
the next continuing HBO therapy session. Further research with more dose variations 
(between 1-5 sessions and between 5-10 sessions) is needed to obtain the optimal dose of the 
Hyperbaric Oxygen therapy for acute wounds without infections. Further research needs to be 
conducted to determine the repetition time interval after the administration of the Hyperbaric 
Oxygen therapy in5 sessions (recovery period) as well as the use of HBO as an adjuvant 
therapy for various types of injuries. 
 
4. Conclusion 
This study concludes that applying 2.4 ATA HBO for 3x30 minutes in 5 sessions increases 
the expressions of e-NOS, TNF-α, VEGF and accelerates wound healing, while giving HBO 
2.4 ATA for 3x30 minutes in 10 sessions enhances the expression of e-NOS, TNF-α and 
VEGF but does not accelerate wound healing. 
Furthermore, the evidence shows that giving HBO can accelerate wound healing through 
mechanisms of e NOS, TNF-α and, VEGF expression. The HBO administration can be 
potentially used for a post-surgical adjuvant therapy and specific cases as the administration is 
expected to shorten the duration of treatment in the hospitals, and reduce the cost and 
recovery time for patients after surgery so that they can return to normal activities. 
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